RNA Research

Grant awarded to advance RNA interference technology used for gene analysis

Published in Genomics and Genetics Weekly, November 8th, 2002

Ambion, Inc. (Austin, Texas, has been awarded a phase I SBIR grant valued at $221,000 from the U.S. National Institute of General Medical Sciences (NIGMS) to further the development of short interfering RNA (siRNA) technologies.

siRNA are double-stranded RNA of approximately 20 base pairs that block or decrease the expression of specific gene targets. A comprehensive study of siRNA is proposed in this grant with aims of improving the basic technology by improving target site selection, optimizing delivery of the siRNA into cells, and characterizing the general features of siRNA that maximize its efficacy.

siRNA technology will enable researchers to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly

Source: Genomics and Genetics Weekly (2002-11-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry